Yüklüyor......
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
BACKGROUND: Ovarian cancer is the sixth most common cancer and seventh most common cause of cancer death in women world‐wide. Three‐quarters of women present when the disease has spread throughout the abdomen (stage III or IV) and treatment consists of a combination of debulking surgery and platinum...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457589/ https://ncbi.nlm.nih.gov/pubmed/25991068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007929.pub3 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|